Tempur Sealy International Inc (NYSE:TPX) faces challenges with a 1.5% sales decline in Q1 FY24 to $1.189 billion, missing estimates. North American sales drop 2.3% Y/Y, while international sales fall 1.6% on a constant currency basis.
Discover results from Sanofi's Phase 2 study on frexalimab for relapsing multiple sclerosis. Explore sustained reduction in disease activity and lesion numbers with low relapse rates.
The long-slumbering cannabis sector has reawakened on a string of recent news items including Germany's partial legalization and possible rescheduling of marijuana in the United States. Tim Seymour, founder and CIO of Seymour Asset Management, joined Benzinga's PreMarket Prep Wednesday and discussed his views on the current "exciting times in cannabis."